-+ 0.00%
-+ 0.00%
-+ 0.00%

PROCEPT BioRobotics Affirms FY2026 Sales Guidance of $390.000M-$410.000M vs $397.424M Est

Benzinga·08/04/2026 20:16:15
Listen to the news
PROCEPT BioRobotics (NASDAQ:PRCT) affirms FY2026 sales outlook from $390.000 million-$410.000 million to $390.000 million-$410.000 million vs $397.424 million estimate.